Royalty Pharma plc
RPRX
DELAYED 1 MONTH
18 insider filings · Latest: Jun 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 26, 2026 | May 28 8:48 PM | Terrance P. CoyneEVP & CFO | Sale | 64,399 | $53.98 | $3.5M | 0(I) | View → |
| May 20, 2026 | May 22 1:20 AM | Marshall UristEVP, Research & Investments | Sale | 13,684 | $52.75 | $721.8K | 18,197(D) | View → |
| May 14, 2026 | May 15 8:38 PM | Marshall UristEVP, Research & Investments | Sale | 13,684 | $53.06 | $726.1K | 31,881(D) | View → |
| May 14, 2026 | May 15 8:37 PM | Gregory NordenDirector | Sale | 3,045 | $53.00 | $161.4K | 191,803(D) | View → |
| Apr 28, 2026 | Apr 30 9:54 PM | Terrance P. CoyneEVP & CFO | Sale | 34,791 | $49.78 | $1.7M | 40,136(I) | View → |
| Mar 2, 2026 | Mar 4 10:11 PM | Terrance P. CoyneEVP & CFO | Sale | 34,791 | $46.78 | $1.6M | 45,761(I) | View → |
Stock Options & Derivatives
No transactions found.